Counter Drone Tech Firm Differs From Rest of Market
Source: Daniel Laing   (9/27/22)
This company warrants a favorable investment thesis and Buy recommendation based on many factors, noted a Bell Potter report. More >

Oncology Co.'s Shares Erupt on Signing Global License Deal
Source: Streetwise Reports  (9/27/22)
Shares of clinical-stage immuno-oncology company LAVA Therapeutics NV traded nearly 100% higher yesterday after the firm reported that it has entered into a global licensing agreement with Seagen Inc. to advance its LAVA-1223, a preclinical gamma delta bispecific T cell engager designed for use in the treatment of EGFR-expressing solid tumors. More >

Opportunity for Investors Found in Psychedelics Space
Source: Patrick R. Trucchio  (9/27/22)
Treatment of alcohol use disorder with psychedelics plus therapy is effective, according to existing data, and the potential global market is large, noted an H.C. Wainwright & Co. report. More >

Solar Co. Amps Up Power Generating Assets
Source: Streetwise Reports  (9/27/22)
Altus Power Inc. shares traded 17% higher to a new 52-week high after the industrial, public and community solar firm reported it entered into definitive agreements to acquire 97 megawatts of operating solar assets. More >

The Perfect Storm for Oil and Natural Gas
Source: Ron Struthers  (9/27/22)
Numerous positive influences on oil and gas prices are looking to converge this winter in North America and Europe. Expert Ron Struthers believes oil and gas stocks have been oversold and offer very good value, and he highlights two he thinks are worth your attention. More >

US Biotech Firm Keeps Growing Revenue
Source: Scott Henry  (9/26/22)
Revenue last quarter was strong, and management expects to increase revenue 20% this fiscal year, noted a ROTH Capital Partners report. More >

Junior Sells Lithium Projects to Focus on James Bay Gold
Source: Streetwise Reports  (9/26/22)
Quebec Precious Metals Corp. is selling all of its non-core assets so it can focus on its flagship Sakami gold project in the James Bay territory of Quebec. More >

Lithium Explorer Partners With Leading Battery Maker
Source: Streetwise Reports  (9/26/22)
Snow Lake Resources Ltd.'s shares traded 38% higher Friday after the company reported it signed an MOU with global lithium-ion battery manufacturer LG Energy Solution. Under the terms of the proposed agreement, the firms will collaborate to develop and build a lithium hydroxide processing plant in Winnipeg, Man. capable of supplying LG Energy with lithium over a 10-year period beginning in 2025. More >

New Assays Highlight High Copper Potential
Source: Streetwise Reports  (9/26/22)
Norseman Silver has just announced more high-grade assays of rock chip samples at its project in Argentina. More >

Sampling at Argentina Project Reveals Elevated Copper/Gold Values
Source: Michael Ballanger  (9/26/22)
Michael Ballanger explains why he believes sample assays provide evidence "indicating the potential for world-class scale and value." More >

Six Charts You Need To See Showing the Coming Bear Market
Source: Michael Ballanger  (9/26/22)
Expert Michael Ballanger takes a look at a few charts to tell you how he believes the US dollar is doing and where he thinks the market may be heading. More >

Green Tech Co. Uplisted to OTCQB Venture Market
Source: Streetwise Reports  (9/26/22)
Bioleaching company BacTech Environmental Corp. has begun trading on the OTCQB Venture Market as it gets ready to open a plant in Ecuador and has opened a pilot facility in Ontario. More >

Co.'s Clinical Program in HPV+ Cancers Gives It a Buy Rating
Source: Dr. Joseph Pantginis  (9/23/22)
To fund continued development of its lead immunotherapy candidate, the U.S.-based biopharma recently completed a $35 million debt financing agreement, noted an H.C. Wainwright & Co. report. More >

Analyst Says Buy Before Biotech Co.'s Clinical Trials
Source: Dr. David Nierengarten  (9/23/22)
Argenx SE has "several upcoming catalysts," noted a Wedbush report. More >

Cobalt Refiner Signs 3-Yr. Supply Deal With EV Battery Maker
Source: Streetwise Reports  (9/23/22)
Shares of Electra Battery Materials Corp. traded 13% higher yesterday after the company reported it entered into a 3-year supply agreement with LG Energy Solution of South Korea to provide 7,000 tonnes of cobalt sulfate for use in manufacturing batteries for electric vehicles in North America. More >

Gold Co. 'Looking Like a Good Value'
Source: Clive Maund  (9/23/22)
With good news shown on Tuesday, Strikepoint Gold Inc. has piqued expert Clive Maund's interest. Today he reviews the gold company's 3-year and 6-month charts to tell you where he believes the stock is headed. More >

Junior Sells Yukon Projects To Focus on Golden Triangle
Source: Streetwise Reports  (9/22/22)
StrikePoint Gold Inc. is selling its Yukon Territory properties so it can better focus on its flagship Porter and Willoughby projects in the Golden Triangle. More >

Timing the US Market Crash: A Roadmap
Source: Clive Maund  (9/22/22)
Expert Clive Maund reviews the charts for the broad stock market to tell you when he believes the U.S. market will crash. More >

Telemedicine Co. Says It's Set To Thrive in Post-Pandemic World
Source: Streetwise Reports  (9/21/22)
The pandemic changed the way many people get their basic healthcare, giving a big opening to telemedicine companies like Reliq Health Technologies Inc. More >

Expert Says Silver Co. Is a Buy up to CA$0.20
Source: Michael Ballanger  (9/21/22)
Expert Michael Ballanger reflects on his views of Norseman Silver last April to compare his opinion of the company then versus what he sees now. More >

FDA Approves Hearing Loss Drug for Child Chemo Patients
Source: Streetwise Reports  (9/21/22)
Shares of Fennec Pharmaceuticals Inc. traded 14% higher after the company reported it received approval from the U.S. FDA for its PEDMARK® (sodium thiosulfate injection) for use in reducing the risk of ototoxicity in pediatric patients who are undergoing or completed chemotherapy for non-metastatic solid tumors. More >

Dermatology Co.'s Target Price Much Higher Than Current
Source: Dr. Jonathan Aschoff  (9/20/22)
The biopharma's strategic marketing campaign "should continue growing U.S. sales to current and new customers," noted a ROTH Capital Partners report. More >

Important Catalyst Expected Soon for Cancer Drug Co.
Source: Dr. David Nierengarten  (9/20/22)
The biopharma should announce initial clinical trial data on its lead small molecule candidate by year-end, noted a Wedbush report. More >

Junior Continues Pivot With Nevada Lithium Project
Source: Streetwise Reports  (9/20/22)
Rover Metals Inc. is moving quickly as it eyes the all-important critical metals and minerals sector with a district-scale claystone lithium project in Nevada. More >

Biopharma Co.'s Shares Rise on Phase 3 Migraine Trial Data
Source: Streetwise Reports  (9/20/22)
Satsuma Pharmaceuticals Inc. shares traded 12% higher to a new 52-week high after the company reported positive results from its Phase 3 long-term study of STS101 for use in acute treatment of migraine attacks. The company expects to receive further efficacy data from its Phase 3 SUMMIT trial in Q4/22, which it believes will support submission of an NDA with the U.S. FDA in Q1/23. More >